Halberd CorpOTC Pink - Current Information:HALB
- LAST PRICE0.0037
- TODAY'S CHANGE (%)-0.0003 (-7.5000%)
- Bid / Lots0.0028/ 1,000
- Ask / Lots0.0036/ 474
- Open / Previous Close0.0038 / 0.0040
- Day Range
- 52 Week Range
- Volume984,300
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HALB |
|---|---|---|
| 09:32 ET | 505011 | 0.0027 |
| 09:33 ET | 213089 | 0.0028 |
| 09:35 ET | 300 | 0.00335 |
| 09:39 ET | 100 | 0.00335 |
| 09:48 ET | 1854 | 0.00365 |
| 09:50 ET | 1000 | 0.00365 |
| 09:53 ET | 300 | 0.00365 |
| 10:08 ET | 100 | 0.00365 |
| 11:00 ET | 100 | 0.00365 |
| 12:17 ET | 100 | 0.0039 |
| 12:51 ET | 210000 | 0.0034 |
| 12:55 ET | 200 | 0.00335 |
| 12:57 ET | 100 | 0.00335 |
| 01:20 ET | 100 | 0.00335 |
| 02:23 ET | 246 | 0.00334 |
| 02:48 ET | 100 | 0.0037 |
| 03:10 ET | 1600 | 0.0037 |
| 03:33 ET | 50000 | 0.0037 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Halberd Corp | 2.4M | 1.6x | --- |
Cyclacel Pharmaceuticals Inc | 2.2M | 0.0x | --- |
Sonnet Biotherapeutics Holdings Inc | 2.4M | -0.1x | --- |
Palisade Bio Inc | 3.2M | -0.2x | --- |
Herborium Group Inc | 1.1M | 0.0x | --- |
Lipella Pharmaceuticals Inc | 2.9M | -0.5x | --- |
Company Information
Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.
Contact Information
- Headquarters
- P.O. Box 25JACKSON CENTER, PA, United States 16133
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4M |
|---|---|
Revenue (TTM) | $281.2K |
Shares Outstanding | 635.9M |
Halberd Corp does not pay a dividend. | |
Beta | -4.03 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 1.6x |
Price/Sales (TTM) | 8.4 |
Price/Cash Flow (TTM) | 92.7x |
Operating Margin | 34.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
